Activation of TAAR1 inhibits midbrain dopaminergic and serotoninergic activity and enhances prefrontal glutamatergic neuron function, which has been associated with a variety of psychiatric disorders, including drug addiction, schizophrenia, and attention‐deficit hyperactivity disorder.10, 11. This evidence concerns the gene TAAR1 and schizophrenia.